Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017
-
Gulbarshyn Mukasheva
,
Madina Abenova
,
Askhat Shaltynov
,
Oxana Tsigengage
,
Zhanna Mussabekova
,
Tolkyn Bulegenov
,
Gulnara Shalgumbaeva
,
Yuliya Semenova
Abstract
Background: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality.
Methods: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from “Medinform” company were analyzed based on the annual population statistics.
Results: There was an increase in the incidence of cardiovascular disease among the population of Kazakhstan from 1845.4 per 100,000 in 2004 to 2597.5 per 100,000 in 2017. This might be attributed to the implementation of the national health programs, which improved early CVD identification. Incidence of ischemic heart disease (IHD) was grown almost in all provinces of Kazakhstan during the study period. The mortality from cardiovascular disease had a considerable decline over the study period, in particular after 2010, it might be influenced by early diagnosis and provision of timely treatment.
Conclusion: The experience of Kazakhstan national health programs shows improved identification of CVD and IHD and timely treatment for cardiovascular disease. A significant variation in incidence and mortality rates of cardiovascular disease was observed between the country provinces.
1. WHO. Health topics. Cardiovascular diseases. 2019. Available from: https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1
2. McAloon CJ, Osman F, Glennon P, et al (2016). Global epidemiology and incidence of cardiovascular disease. Cardiovascular Diseases, 57-96.
3. Timmis A, Townsend N, Gale C, et al (2018). European Society of Cardiology: cardiovascular disease statistics 2017. Eur Heart J, 39(7), 508-579.
4. Mahmood SS, Levy D, Vasan RS, et al (2014). The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet, 383(9921), 999-1008
5. Stamler J, Wentworth D, Neaton JD (1986). Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?: findings in 356 222 primary screenees of the multiple risk factor intervention trial (mrfit). JAMA, 256(20), 2823-8.
6. Stamler J, Stamler R, Neaton JD (1993). Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med, 153(5), 598-615.
7. Pavillard LE, Marín-Aguilar F, Bullon P, et al (2018). Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns. Pharmacol Res, 131: 44-50.
8. WHO(2016) Cardiovascular diseases (CVDs) fact sheets.. Available from: https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1
9. Anand SS, Hawkes C, de Souza RJ, et al (2015). Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the World Heart Federation. J Am Coll Cardiol, 66(14), 1590-1614.
10. Benjamin EJ, Muntner P, Alonso A, et al (2019). Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), e56-e528.
11. Stewart J, Manmathan G, Wilkinson P (2017). Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. J JRSM Cardiovasc Dis, 6:2048004016687211.
12. Puska P, Vartiainen E, Nissinen A, et al (2016). Background, principles, implementation, and general experiences of the North Karelia Project. Global Heart, 11(2), 173-8.
13. Government of Kazakhstan (2016). State Programme “densaulyk” for health care system development in republic of kazakhstan 2016 - 2019. Available from: http://www.ecaqa.org/doxs/36.pdf
14. Health care Ministry (2013). Health of the Kazakhstani population and the activities of health organizations in 2012. Available from: www.mzsr.gov.kz/sites/default/files/2013_0.pdf
15. World Health Organization (2013). The European health report 2012: charting the way to well-being. World Health Organization. Regional Office for Europe.
16. Markabayeva A, Bauer S, Pivina L, et al (2018). Increased prevalence of essential hypertension in areas previously exposed to fallout due to nuclear weapons testing at the Semipalatinsk Test Site, Kazakhstan. Environ Res, 167:129-135.
17. Dyussenova L, Pivina L, Semenova Y, et al (2019). Trace element biomonitoring in hair and blood of occupationally unex-posed population residing in polluted ar-eas of East Kazakhstan and Pavlodar re-gions. J Trace Elem Med Biol, 56:31-37.
18. Olga Gromova, Aikerm Doschanova , Vyacheslav Lokshin, et al (2020). Vitamin D deficiency in Kazakhstan: Cross-Sectional study. J Steroid Biochem Mol Biol, 199:105565
19. Program of the meeting board of the Ministry of Health of the Republic of Kazakhstan.(2019) Available from: http://www.rcrz.kz/files/kollegii/Презентация Актаева меры снижения смертности.pdf
20. Analytical material of the extended board of the Ministry of Health of the Republic of Kazakhstan. (2017) Available from: http://www.rcrz.kz/docs/broshura.pdf
21. Dauletyarova M, Semenova Y, Kaylubaeva G, et al (2016). Are women of East Ka-zakhstan satisfied with the quality of ma-ternity care? Implementing the WHO tool to assess the quality of hospital services. Iran J Public Health, 45(6):729-38.
22. Dauletyarova MA, Semenova YM, Kaylubaeva G, et al (2018) Are Kazakh-stani Women Satisfied with Antenatal Care? Implementing the WHO Tool to Assess the Quality of Antenatal Ser-vices.Int J Environ Res Public Health, 15(2): 325.
23. Gawron LM, Pettey WBP, Redd AM, et al (2017). Distance to Veterans Administration Medical Centers as a Barrier to specialty care for homeless women Veterans. Stud Health Technol Inform, 238:112-115.
24. Yelissinova N, Grjibovski AM, Yelissinova A, et al (2015). Sociodemographic factors associated with infant abandonment in maternity hospitals in Kazakhstan: A case–control study. Public Health, 129(7):1010-3.
25. Wang Q, Mati K. (2019). Intention to Quit among Smokers in Kazakhstan: Data from 2014 Global Adult Tobacco Survey. J Epidemiol Glob Health, 9(1): 23–28.
26. Drafts of the law regulatory document “People’s Health and the Health Care System” and the State Program for Improving Public Health for 2020–2025 (2019) Available from: http://www.rcrz.kz/images/Presentation_public_050619.pdf
2. McAloon CJ, Osman F, Glennon P, et al (2016). Global epidemiology and incidence of cardiovascular disease. Cardiovascular Diseases, 57-96.
3. Timmis A, Townsend N, Gale C, et al (2018). European Society of Cardiology: cardiovascular disease statistics 2017. Eur Heart J, 39(7), 508-579.
4. Mahmood SS, Levy D, Vasan RS, et al (2014). The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet, 383(9921), 999-1008
5. Stamler J, Wentworth D, Neaton JD (1986). Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?: findings in 356 222 primary screenees of the multiple risk factor intervention trial (mrfit). JAMA, 256(20), 2823-8.
6. Stamler J, Stamler R, Neaton JD (1993). Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med, 153(5), 598-615.
7. Pavillard LE, Marín-Aguilar F, Bullon P, et al (2018). Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns. Pharmacol Res, 131: 44-50.
8. WHO(2016) Cardiovascular diseases (CVDs) fact sheets.. Available from: https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1
9. Anand SS, Hawkes C, de Souza RJ, et al (2015). Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the World Heart Federation. J Am Coll Cardiol, 66(14), 1590-1614.
10. Benjamin EJ, Muntner P, Alonso A, et al (2019). Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), e56-e528.
11. Stewart J, Manmathan G, Wilkinson P (2017). Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. J JRSM Cardiovasc Dis, 6:2048004016687211.
12. Puska P, Vartiainen E, Nissinen A, et al (2016). Background, principles, implementation, and general experiences of the North Karelia Project. Global Heart, 11(2), 173-8.
13. Government of Kazakhstan (2016). State Programme “densaulyk” for health care system development in republic of kazakhstan 2016 - 2019. Available from: http://www.ecaqa.org/doxs/36.pdf
14. Health care Ministry (2013). Health of the Kazakhstani population and the activities of health organizations in 2012. Available from: www.mzsr.gov.kz/sites/default/files/2013_0.pdf
15. World Health Organization (2013). The European health report 2012: charting the way to well-being. World Health Organization. Regional Office for Europe.
16. Markabayeva A, Bauer S, Pivina L, et al (2018). Increased prevalence of essential hypertension in areas previously exposed to fallout due to nuclear weapons testing at the Semipalatinsk Test Site, Kazakhstan. Environ Res, 167:129-135.
17. Dyussenova L, Pivina L, Semenova Y, et al (2019). Trace element biomonitoring in hair and blood of occupationally unex-posed population residing in polluted ar-eas of East Kazakhstan and Pavlodar re-gions. J Trace Elem Med Biol, 56:31-37.
18. Olga Gromova, Aikerm Doschanova , Vyacheslav Lokshin, et al (2020). Vitamin D deficiency in Kazakhstan: Cross-Sectional study. J Steroid Biochem Mol Biol, 199:105565
19. Program of the meeting board of the Ministry of Health of the Republic of Kazakhstan.(2019) Available from: http://www.rcrz.kz/files/kollegii/Презентация Актаева меры снижения смертности.pdf
20. Analytical material of the extended board of the Ministry of Health of the Republic of Kazakhstan. (2017) Available from: http://www.rcrz.kz/docs/broshura.pdf
21. Dauletyarova M, Semenova Y, Kaylubaeva G, et al (2016). Are women of East Ka-zakhstan satisfied with the quality of ma-ternity care? Implementing the WHO tool to assess the quality of hospital services. Iran J Public Health, 45(6):729-38.
22. Dauletyarova MA, Semenova YM, Kaylubaeva G, et al (2018) Are Kazakh-stani Women Satisfied with Antenatal Care? Implementing the WHO Tool to Assess the Quality of Antenatal Ser-vices.Int J Environ Res Public Health, 15(2): 325.
23. Gawron LM, Pettey WBP, Redd AM, et al (2017). Distance to Veterans Administration Medical Centers as a Barrier to specialty care for homeless women Veterans. Stud Health Technol Inform, 238:112-115.
24. Yelissinova N, Grjibovski AM, Yelissinova A, et al (2015). Sociodemographic factors associated with infant abandonment in maternity hospitals in Kazakhstan: A case–control study. Public Health, 129(7):1010-3.
25. Wang Q, Mati K. (2019). Intention to Quit among Smokers in Kazakhstan: Data from 2014 Global Adult Tobacco Survey. J Epidemiol Glob Health, 9(1): 23–28.
26. Drafts of the law regulatory document “People’s Health and the Health Care System” and the State Program for Improving Public Health for 2020–2025 (2019) Available from: http://www.rcrz.kz/images/Presentation_public_050619.pdf
| Files | ||
| Issue | Vol 51 No 4 (2022) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v51i4.9243 | |
| Keywords | ||
| Incidence Mortality Republic of Kazakhstan Cardiovascular disease Ischemic heart disease | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Mukasheva G, Abenova M, Shaltynov A, Tsigengage O, Mussabekova Z, Bulegenov T, Shalgumbaeva G, Semenova Y. Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017. Iran J Public Health. 2022;51(4):821-830.
